Immunohistochemical analysis revealed that this tumor was positive for PSA and androgen receptor (AR) and negative for chromogranin and synaptophysin, suggesting that the metastatic lesion unlikely had neuroendocrine differentiation (Fig. 3). The gene discussed is KLK3; the disease is neoplasm.